Coronavirus envelope protein activates TMED10-mediated unconventional secretion of inflammatory factors
Lei Liu, Lijingyao Zhang, Xinyan Hao, Yang Wang, Xiaochun Zhang, Liang Ge, Pei‐Hui Wang, Boxue Tian, Min Zhang
Abstract
The precise cellular mechanisms underlying heightened proinflammatory cytokine production during coronavirus infection remain incompletely understood. Here we identify the envelope (E) protein in severe coronaviruses (SARS-CoV-2, SARS, or MERS) as a potent inducer of interleukin-1 release, intensifying lung inflammation through the activation of TMED10-mediated unconventional protein secretion (UcPS). In contrast, the E protein of mild coronaviruses (229E, HKU1, or OC43) demonstrates a less pronounced effect. The E protein of severe coronaviruses contains an SS/DS motif, which is not present in milder strains and facilitates interaction with TMED10. This interaction enhances TMED10-oligomerization, facilitating UcPS cargo translocation into the ER-Golgi intermediate compartment (ERGIC)—a pivotal step in interleukin-1 UcPS. Progesterone analogues were identified as compounds inhibiting E-enhanced release of proinflammatory factors and lung inflammation in a Mouse Hepatitis Virus (MHV) infection model. These findings elucidate a molecular mechanism driving coronavirus-induced hyperinflammation, proposing the E-TMED10 interaction as a potential therapeutic target to counteract the adverse effects of coronavirus-induced inflammation. It remains unclear why a heightened proinflammatory cytokine response is observed during coronavirus infection. Here, Liu et al show that the envelope protein of severe coronaviruses triggers hyperinflammation by activating TMED10-mediated release of inflammatory factors.